Search

everythinglearnresearchcommunity

for

Search:↓

ODAC members faced intense pressure but prioritized scientific evidence in drug approval decisions.

Exosomes show promise in dermatology but need more research and FDA approval for clinical use.

Nanotechnology shows promise for treating hair loss but faces safety and approval challenges.

Restolin Hair Supplement may help hair growth but lacks FDA approval and clinical trial evidence.

Mesenchymal stem cell therapy shows promise for liver disease but faces challenges in standardization and approval.

The document warns against US clinics selling untested stem cell treatments without FDA approval.

The US and EU lead in cell and gene therapy regulations with more approvals and clinical trials, while India is in early stages with fewer approvals and expedited processes.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Thermoresponsive nanogels show promise for delivering medicine through the skin but need more safety testing and regulatory approval before clinical use.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

More men are using medication for benign prostatic hyperplasia, influenced by marketing and FDA approvals.

Exosomes may improve hair growth, but more research is needed for safety and approval.

Drug repurposing speeds up drug development, saves money, and has led to about a third of new drug approvals.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

Haloperidol effectively treated hemiballismus, but spontaneous improvement wasn't ruled out; rapid weight loss can cause hair loss with good regrowth chances.

The committee decided not to approve the drug due to low effectiveness and high risks.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

New psoriasis treatments are effective but come with side effects and risks.

Endogenous neurosteroids may set a baseline mood.

Unapproved stem cell therapies are marketed online in the UK, raising safety and regulation concerns.

JAK inhibitors offer new hope for treating severe alopecia areata.

Biofibre® hair implants are safe and effective for alopecia when proper procedures are followed, with high patient satisfaction.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

The conclusion is that off-label drug use can lead to important medical discoveries and improve patient care.